61323-28-2

Basic information

• Product Name: 4-Thiazolecarboxylic acid, 5-phenyl-, ethyl ester
• Synonyms: 4-Thiazolecarboxylic acid, 5-phenyl-, ethyl ester;ethyl 5-phenylthiazole-4-carboxylate
• CAS NO: 61323-28-2
• Molecular Formula: C₁₂H₁₁NO₂S
• Molecular Weight: 233.28624
• Mol File: 61323-28-2.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Thiazolecarboxylic acid, 5-phenyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Thiazolecarboxylic acid, 5-phenyl-, ethyl ester(61323-28-2)
• EPA Substance Registry System: 4-Thiazolecarboxylic acid, 5-phenyl-, ethyl ester(61323-28-2)

Safety Data

• Hazardous Substances Data: 61323-28-2(Hazardous Substances Data)

Upstream product

• 936-61-8 Thiobenzoic acid O-ethyl ester 
• 2999-46-4 Ethyl isocyanoacetate 
• 161198-54-5 methyl N-(ethoxycarbonylmethyl)thioformimidate 
• 3154-51-6 ethyl N-formylglycinate 
• 82954-40-3 N-thioformyl glycine ethyl ester 
• 773837-37-9 sodium cyanide 
• 2168-78-7 methyl dithiobenzoate 
• 61830-23-7 ethyl 5‐bromo‐1,3‐thiazole‐4‐carboxylate 
• 98-80-6 phenylboronic acid 
• 98-91-9 thiobenzoic acid 

Downstream Products

• 838893-03-1 (5-phenylthiazole-4-yl)methanol 
• 127917-64-0 t-butyl [2-(5-phenyl-4-thiazolecarboxamido)ethyl]carbamate 
• 1047671-69-1 1-methyl-4-{[(5-phenyl-1,3-thiazol-4-yl)carbamoyl]oxy}-1-azoniabicyclo[2.2.2]octane iodide 
• 1047671-76-0 (3R)-1-methyl-3-{[(5-phenyl-1,3-thiazol-4-yl)carbamoyl]oxy}-1-azoniabicyclo[2.2.2]octane iodide 
• 13743-14-1 5-phenyl-1,3-thiazole-4-carboxylic acid 
• 1047672-25-2 1-azabicyclo[2.2.2]oct-4-yl (5-phenyl-1,3-thiazol-4-yl)carbamate 
• 1047672-88-7 (3R)-1-azabicyclo[2.2.2]oct-3-yl (5-phenyl-1,3-thiazol-4-yl)carbamate hydrochloride 

Relevant articles and documents

IAP ANTAGONISTS AND THEIR THERAPEUTIC APPLICATIONS

The present invention relates to Formula I. compounds including their isomers, tautomeric forms and rotamers, salts together with their manufacturing process and their pharmacological use alone or in combination with other active ingredients for the treatment of cell and tissue malignances caused diseases, including uncontrolled cell or tissue growth, proliferation and cancer.

Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists

Herein, we describe the synthesis and pharmacological profiles of novel quinuclidinyl heteroarylcarbamate derivatives. Among them, the quinuclidin-4-yl thiazolylcarbamate derivative ASP9133 was identified as a promising long-acting muscarinic antagonist (LAMA) showing more selective inhibition of bronchoconstriction against salivation and more rapid onset of action in a rat model than tiotropium bromide.

ARYL GPR120 RECEPTOR AGONISTS AND USES THEREOF

Aryl GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.